{"id":"NCT03377790","sponsor":"Verrica Pharmaceuticals Inc.","briefTitle":"Cantharidin Application in Molluscum Patients-1","officialTitle":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-03-21","primaryCompletion":"2018-11-26","completion":"2018-11-26","firstPosted":"2017-12-19","resultsPosted":"2021-12-14","lastUpdate":"2022-01-11"},"enrollment":266,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Molluscum Contagiosum"],"interventions":[{"type":"COMBINATION_PRODUCT","name":"VP-102 - Cantharidin, Topical Film Forming Solution","otherNames":[]},{"type":"COMBINATION_PRODUCT","name":"Placebo -Topical Film Forming Solution without VP-102","otherNames":[]}],"arms":[{"label":"VP-102","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is a Phase 3, randomized, double-blind, placebo-controlled, pivotal study to evaluate the safety and efficacy of VP-102 topical film-forming solution in subjects with Molluscum Contagiosum. VP-102 will be applied once every 21 days for up to 4 applications, to treatable molluscum contagiosum (molluscum) lesions on subjects 2 years and older. Efficacy will be assessed as the proportion of subjects achieving complete clearance of all treatable molluscum lesions (baseline and new) on the Day 84 visit.","primaryOutcome":{"measure":"Percentage of Subjects Exhibiting Complete Clearance of All Treatable Molluscum Lesions (Baseline and New) on the Day 84 Visit (EOS)","timeFrame":"Day 1 (Baseline and new) compared to Day 84 (EOS)","effectByArm":[{"arm":"VP-102","deltaMin":74,"sd":null},{"arm":"Placebo","deltaMin":19,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":18,"countries":["United States"]},"refs":{"pmids":["34976290","33599960","32965495"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":161},"commonTop":["Application site vesicles","Application site pruritus","Application site pain","Application site erythema","Application site scab"]}}